Publikationen von Roman K. Thomas
Alle Typen
Zeitschriftenartikel (72)
2023
Zeitschriftenartikel
4 (1), S. 78 - 97 (2023)
Distinct genetically determined origins of Myd88/BCL2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood Cancer Discovery 2022
Zeitschriftenartikel
21 (5), S. 821 - 830 (2022)
CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization. Molecular Cancer Therapeutics 2015
Zeitschriftenartikel
16, 7 (2015)
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data. Genome Biology
Zeitschriftenartikel
526 (7575), S. 700 - 704 (2015)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 2014
Zeitschriftenartikel
4 (4), S. 415 - 422 (2014)
CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discovery
Zeitschriftenartikel
4 (2), S. 246 - 257 (2014)
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discovery 2013
Zeitschriftenartikel
123 (4), S. 1732 - 1740 (2013)
Tumor vegf:vegfr2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation
Zeitschriftenartikel
5 (209), 209ra153 (2013)
A genomics-based classification of human lung tumors. Science Translational Medicine 2012
Zeitschriftenartikel
51 (1), S. 54 - 65 (2012)
Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm. Genes Chromosomes and Cancer
Zeitschriftenartikel
18 (17), S. 4682 - 4690 (2012)
Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants. Clinical Cancer Research
Zeitschriftenartikel
31 (20), S. 3961 - 3975 (2012)
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis. EMBO Journal
Zeitschriftenartikel
150 (6), S. 1107 - 1120 (2012)
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell
Zeitschriftenartikel
44 (10), S. 1104- - 11xx (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics
Zeitschriftenartikel
18 (9), S. 2443 - 2451 (2012)
Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clinical Cancer Research
Zeitschriftenartikel
77 (3), S. 617 - 620 (2012)
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [ 18F]fluorothymidine (FLT-)PET. Lung Cancer
Zeitschriftenartikel
109 (42), S. 17034 - 17039 (2012)
A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America
Zeitschriftenartikel
31 (46), S. 4811 - 4814 (2012)
Genetic insight and therapeutic targets in squamous-cell lung cancer. Oncogene
Zeitschriftenartikel
489 (7417), S. 519 - 525 (2012)
Comprehensive genomic characterization of squamous cell lung cancers. Nature
Zeitschriftenartikel
35 (Suppl. 1), S. 14 - 19 (2012)
Personalized therapy of lung cancer. Onkologie 2011
Zeitschriftenartikel
3 (90), S. 90ra59 - 90ra59 (2011)
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Science Translational Medicine